Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Shock, Septic × Saline Solution × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 3 Neoplasms 2 Warts 1 Urinary Bladder Neoplasms 1 Spinal Cord Neoplasms 1 Shock, Septic 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion 1 Papillomavirus Infections 1 Liver Neoplasms 1 Depression 1 Carcinoma, Hepatocellular 1

Interventions

Saline Solution 1 Methylene Blue 1 Contraceptives, Oral 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06005558 2024-07-05

Low Dose Versus High Dose Methylene Blue in Septic Patients

National Cancer Institute, Egypt

Phase 2/3 Completed

Shock, Septic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡